研究業績

2024

1. Inoue M, Masukawa D, Goshima Y., L-DOPA receptor GPR143 inhibits neurite outgrowth via L-type calcium channels in PC12 cells. J. Pharmacol Sci., 156(1):45-48, 2024.
2. Arai M, Suzuki E, Kitamura S, Otaki M, Kanai K, Yamasaki M, Watanabe M, Kambe Y, Murata K, Takada Y, Arisawa T, Kobayashi K, Tajika R, Miyazaki T, Yamaguchi M, Lazarus M, Hayashi Y, Itohara S, d’Exaerde AK, Nawa H, Kim R, Bito H, Momiyama T, Masukawa D, Goshima Y., Enhancement of haloperidol-induced catalepsy by GPR143, an L-DOPA receptor, in striatal cholinergic interneurons. J Neurosci., 44(11):1504-1523. 2024.

2023

1. Masukawa D, Takahagi R, Nakao Y, Goshima Y., L-DOPA Receptor GPR143 Functionally Couples with Adrenergic α_1B Receptor at the Second Transmembrane Interface. Biol. Pharm. Bull., 46(7):869-873, 2023.
2. Sugioka S, Yamada H, Ishii A, Kato Y, Yamada R, Mori KP, Ohno S, Handa T, Ikushima A, Ishimura T, Osaki K, Tokudome T, Matsusaka T, Nebreda AR, Yanagita M, Yokoi H., Dual deletion of guanylyl cyclase-A and p38 mitogen-activated protein kinase in podocytes with aldosterone administration causes glomerular intra-capillary thrombi. Kidney Int., S0085-2538(23)00425-8, 2023.
3. Uchimura H, Kanai K, Arai M, Inoue M, Hishimoto A, Masukawa D, Goshima Y., Involvement of the L-DOPA receptor GPR143 in acute and chronic actions of methylphenidate. J. Pharmacol. Sci., 165(2):177-195, 2023.
4. Masukawa D, Kitamura S, Tajika R, Uchimura H, Arai M, Takada Y, Arisawa T, Otaki M, Kanai K, Kobayashi K, Miyazaki T, Goshima Y., Coupling between GPR143 and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L-3,4-dihydroxyphenylalanine in the dorsal striatum. J. Neurochem., 165(2):177-195, 2023.